Marketresearchnews

Thursday, 27 August 2020

Microbiology Testing Market Size And Key Trends In Terms Of Volume And Value 2019

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Microbiology Testing Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

The global microbiological testing market was valued at USD 2706.1 Mn in 2016 and is due to reach USD 5409.1 Mn by the end 2023, affirms Market Research Future (MRFR) in a detailed study.

Technological advancements in microbiology which expedite infection diagnosis and provide more reliable results have gained significant traction in recent years. Rising cases of infectious diseases have provided fodder for the growth of the microbiological testing market. The outbreak of several disease epidemic across the globe have spurred demand for microbiological testing services. This has resulted in an increase in research funding and a substantial increase in healthcare expenditure on a global scale. Surveillance Programs aimed at disease control and growing stringency of safety standards are other factors substantiating the growth of the global microbiology testing market. Furthermore, traditional laboratory techniques have become almost obsolete and have lost grounds to advanced microbiological testing methods.

Also Read : https://www.medgadget.com/2019/11/microbiology-testing-market-2019-size-share-trends-opportunities-growth-factors-key-players-and-regional-forecast-2023.html

The food industry is a major end user of the global microbiology testing market which generates continual demand for microbiological testing. Ensuring food safety is of paramount importance in the food industry. Food manufacturers incur huge economic losses due to contamination and spoilage from bacteria. Moreover, regulatory bodies mandate microbiological testing of food items before it is put up for sale in the market. Food manufacturers extensively utilize microbiological testing to quantify and detect pathogenic spoilage and microorganisms.

On the downside, the market growth of microbiology testing is at threat from erroneous results and the high cost of reagents and instruments. However, increase in R&D activities coupled with grants for the same is expected to provide opportunities for market growth. However, tightened government regulations and policies are likely to remain as challenges to market growth.

Segmentation

The global microbiology testing market has been segmented based on type, application, and end user.

By type, the global microbiology testing market has been segmented into instruments, chemicals & reagents, consumables & accessories, and others. The chemicals & reagents segment holds around 42.1% share of the global market.

By application, the global microbiology testing market has been segmented into gastrointestinal infections, respiratory infections, urinary tract infections, sexually transmitted infections, and others.

By end user, the global microbiology testing market has been segmented into hospital-based laboratory, independent laboratory, and academics & research institutes.

Regional Analysis

By region, the global microbiology testing market has been segmented into North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

North America accounts for the foremost share of 37.9% of the global market. Presence of sophisticated laboratory infrastructure and high adoption rate of advanced diagnostic procedures. High prevalence of diseases in the region has resulted in heavy amounts being poured in to support microbiology-based research which has further favored the market growth in the region.

APAC market is estimated to showcase rapid growth over the forecast period. Increasing patient pool and remarkable healthcare spending by the emerging economies of the region and considerable increase in testing and laboratory facility. APAC market is expected to expand at a CAGR of 12.1% over the forecast period.

Europe market is likely to showcase significant growth on account of extensive R&D activities purveyed by state-of-the-art testing infrastructure. The MEA market is expected to showcase sluggish growth over the forecast period.

Competitive Landscape

Biomérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), BD (US), Beckman Coulter, Inc. (US), Cepheid (US), and Alere (US) are the notable players in the global microbiology testing market.

Industry Updates

February 2019 – bioMérieux, Inc., a global leader in in-vitro diagnostics, offering microbiological testing solutions for medical applications, has announced the acquisition of Invisible Sentinel, developer, manufacturer, and marketer of molecular diagnostic tool. The acquisition will help bioMérieux strengthen its position in food pathogen testing and spoilage organism detection segment.

August 2018 – Neogen Corporation, an international food safety company, announced the acquisition of Clarus Labs, Inc. The acquisition includes the patented Colitag water test.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/microbiology-testing-market-697

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

A High Double-Digit Cagr Projected For Precision Medicine Market During 2019-2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Precision Medicine Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Precision medicine refers to medicines developed as per an individual’s genetic profile that helps as a guide for the prevention, diagnosis and treatment of diseases.

Major driving factor for precision medicine market are demand for customised and personalized medicine, growing awareness about the possible applications of precision medicine, growing diagnosis and screening of genetic diseases, increase of risk factors such as UV rays, pollution, cancer among others. The larger investments and the associated development of better infrastructure is a silver lining of the market for precision medicine market.

Also Read : https://www.medgadget.com/2020/02/precision-medicine-market-will-register-a-cagr-of-12-48-appraise-to-reach-usd-126-14-billion-by-2025.html

The market constraints include concerns of data security and privacy, high diagnostic costs, stringent regulations and standards, reimbursement policies and regulatory framework, limited knowledge about the application of test and techniques, lack of research and evidences creating hindrances in its application. The nascent nature of the technology has led to a limited application of the precision medicine. Thus low volumes is a strong barrier as it increases the cost of the final product to customers. The scarcity of trained professionals is acting as a drag on the market.

Precision medicine is an upcoming branch in the healthcare industry with the focus on determining appropriate approaches effective in treating patients based on environment, genetics, and lifestyle factors. Recent advances in genomics and cancer has propelled this particular branch to the forefront. The global precision medicine market report by Market Research Future (MRFR) asserts several determinants and challenges for the period between 2019 and 2025 (forecast period).

Precision Medicine Market Competitive Outlook

Intel Corporation, Sanofi Pharma, Roche Holding AG-Br, Teva Pharmaceutical Industries Ltd., AB-Biotics SA, Cepheid Inc., Takeda Pharmaceutical Company Limited, InnVentis, Pfizer Inc, ABBOTT LABORATORIES, ASURAGEN, INc., bioMérieux SA, HealthCore, Inc., IBM, Glaxosmithkline Plc (GSK), Almac Group, Ltd., Medtronic, Randox Laboratories Ltd, Qiagen, BIOBASE GmbH (Subsidiary), Molecular Health GmbH, GE Healthcare, Novartis, Precision for Medicine, LABORATORY CORPORATION OF AMERICA HOLDINGS, CETICS Healthcare Technologies GmbH, Quest Diagnostics Inc., Caris Life Sciences, Johnson & Johnson, and Intomics A/S are some of the eminent names in the global precision medicine market.

Precision Medicine Market Outlook

Global precision medicine market is expected to exhibit 12.64% CAGR during the forecast period to touch a valuation of USD 126.14 billion by 2025. It is primarily driven by cancer care and advances in palliative care. Development in next-generation sequencing technologies, rising prevalence of genetic diseases, potential for targeted therapies, and integration of big data healthcare companies with pharma & biotech companies.

The cure in rare diseases and the scope of artificial intelligence assisting in the drug development process can widen the market scope drastically. For instance, two novel drugs BAN 2401 and Anavex 2-73 were approved by federal agencies for patients with Alzheimer’s disease. But concerns of data privacy can hamper the market growth.

Precision Medicine Market Segmentation Analysis

The global precision medicine market has been segmented into ecosystem players, sub-markets, and therapeutics.

Based on ecosystem players, the global precision medicine market has been segmented into diagnostic companies, pharmaceuticals and biotechnology companies, healthcare IT specialists/big data companies, and clinical laboratories. The diagnostic tool companies segment accounted for a market value of USD 16.27 million in 2017.

Based on sub-markets, the global precision medicine market has been segmented into pharmacogenomics (PGX), targeted therapeutics, companion diagnostics, biomarker-based test, molecular diagnostics, and others.

Based on therapeutics, the global precision medicine market has been segmented into infectious diseases, cancer/oncology, cardiovascular disease (CVD), central nervous system, and others.

Precision Medicine Market Regional Analysis

The Americas, Asia Pacific (APAC), Europe, and Rest-of-the-World (RoW) are prime regions of interest which have been discussed in detail in the global precision medicine market report.

The Americas is anticipated to dominate the global market during the forecast period due to advances in genome mapping, and initiatives in gene sequencing. In 2015, the U.S. government launched the Precision Medicine Initiative for encouraging new developments in the sector.

The Europe precision medicine market can be the second-largest due to adoption of precise diagnostic tools, electronic health records, and drugs prescribed solely for the disease. Investments in the sector due to the large scope in targeted therapies can drive the global market growth. Mergers and acquisitions can further facilitate market growth.

The APAC region had accounted for a market share of 14% in 2017. It can exhibit a robust CAGR during the forecast period due to emerging developments in healthcare infrastructure and rise in expendable income levels of patients.

Precision Medicine Industry Update

Evotec, a German drug development company, has decided to partner with Bayer AG for expanding their treatment options focusing on women’s health. In collaboration with Celmatix Inc, it is planning to determine the effects of precision medicine for the treatment of polycystic ovary syndrome (PCOS) among women. Both companies will investigate new drug targets and high-technology platforms.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/precision-medicine-market-925

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Injectable Drug Delivery Devices Market Production, Capacity, Revenue, Price, Gross Margin Analysis And Forecast 2019-2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Injectable Drug Delivery Devices

Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Injectable Drug Delivery Devices Market Overview

Injectable drug delivery devices, including conventional syringes and needle-free & autopen injectors, are utilized to administer medications into the circulatory system. It is considered as the most effective way to ensure a quick response. These devices are extensively used for therapeutic applications to treat medical conditions ranging from cancer to autoimmune disorders.

Also Read : https://www.medgadget.com/2020/03/injectable-drug-delivery-devices-market-to-garner-usd-17401-8-million-by-2023-at-a-cagr-of-11-3.html

Over recent years, there have been various innovative advances in injectable drug delivery devices. An autopen injector is one of the most prominent examples. Autopen injectors are commonly used when a patient is unconscious and needs urgent medical assistance. These innovations were driven by continuous R&D efforts and funding by private as well as public organizations.

As a result, the market witnesses a constant rise in revenues. According to Market Research Future (MRFR), the global injectable drug delivery devices market is expected to reach a valuation of USD 17,401.8 MN by 2023, registering 11.3% CAGR throughout the review period (2018 – 2023). Growing adoption of self-injectable devices and the rising preference of home care settings are the key driving forces.

Furthermore, the increasing prevalence of chronic diseases, growing adoption of self-injectable devices, and increasing uses of biologics are pushing the market growth. Also, rising FDA approvals drive market growth. Additionally, technological advancements, improving outcomes & patients’ experience, beneficial reimbursement policies, and increasing awareness towards healthcare. Are impacting the market growth positively.

On the other hand, safety concerns associated with the risk of cross-contamination and the increasing cost of high-end products are some of the key growth impeders of the market. Also, the introduction of alternative drug delivery systems is a major threat the market is facing today.

Injectable Drug Delivery Devices Market – Segments

The report has been segmented into seven major dynamics.

By Device: Conventional and Self-Injection Devices.

By Therapeutic Application: Hormonal Disorders, Autoimmune Diseases, Cancer, and others.

By Usage Pattern: Curative Pattern and Immunization.

By Site of Delivery: Intramuscular, Subcutaneous, and Intradermal.

By Distribution Channel: Hospital & Retail Pharmacies, Online Platforms, and others.

By Facility of Use: Hospitals & Clinics and Home Care Settings.

By Regions: Americas, Europe, Asia Pacific, Middle East & Africa, and Rest-of-the-World.

Global Injectable Drug Delivery Devices Market – Geographical Analysis

North America heads the global injectable drug delivery devices market. The significant market share attributes to the rising demand for self-administration systems for drugs among the huge patient populaces suffering from chronic diseases such as diabetes and cancer. Besides, the presence of the geriatric population and development in medical technology are supporting the growth of the market.

Additionally, factors such as the high healthcare expenditures, growing biotechnology industry, and the well-developed healthcare sectors in the region foster market growth. Witnessing an augmenting demand, the North American injectable drug delivery devices market is projected to create a revenue pocket of USD 17,401.8 million by 2023, growing at 11.3% CAGR throughout the review period (2018 to 2023).

Europe stands second in the global injectable drug delivery devices market. Factors influencing market growth include a rising preference for home care settings among the geriatric population and growing numbers of patients suffering from chronic diseases. Besides, increasing R&D funding and the growing adoption of these devices in the region foster the growth of the market.

Also, the resurging economy and well-penetrated healthcare sectors in the region act as key tailwinds for the market growth in the region. Germany accounts for the major growth contributor to the regional market owing to its flourishing medical devices markets, whereas, the UK and France follow suit, increasing their investments in the development of injectable drug delivery devices.

The Asia Pacific region is emerged as a promisingly growing market for injectable drug delivery devices. Rapid advances in the related technology and rising economy in countries such as China, Japan, South Korea, and India drive the regional market growth excellently. Furthermore, factors such as the huge patient population opting for self-administered drug delivery systems, rising demand for high quality devices in healthcare, and rapidly developing medical technology is expected to continue driving the growth of the regional market.

Global Injectable Drug Delivery Devices Market – Competitive Landscape

Highly competitive, the global injectable drug delivery devices market appears to be well established with the presence of several notable players. To gain a larger competitive advantage in this market, players adopt strategic initiatives such as collaborations, mergers & acquisitions, and product launch/innovations. These players invest substantially to drive R&D and expansion plans. R&D helps them to bring about novel products while investments in acquisitions & partnerships, help them to increase their global footprints.

Injectable Drug Delivery Devices Market Major Players:

Players leading the injectable drug delivery devices market include Antares Pharma, Eisai Co., Ltd, AstraZeneca, Eli Lilly and Company, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Mylan N.V., Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc., Novo Nordisk, Sanofi, Inovio Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd, among others.

Injectable Drug Delivery Devices Industry/ Innovation/ Related News:

February 19, 2020 — BIOCORP (France), a company specialized in the development & manufacturing of medical devices & smart drug delivery systems, today announced its partnership with iSage Rx, LLC. (the US), a digital therapeutics company engaged in insulin dose optimization. Both companies are committed to integrating their respective technologies to simplify insulin dose capture and optimization. Combining these companies offer the most powerful environment for diabetes digitalization and patient support.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/injectable-drug-delivery-devices-market-1211

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Nasal Drug Delivery Nasal Drug Delivery Market, Segments, Growth And Value

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Nasal Drug Delivery Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Nasal Drug Delivery Market Overview

For the treatment of various respiratory disorders, the drugs are delivered through the nasal tract. Giving the drugs through nasal route enhances the drug’s effects and gradually helps in decreasing the dosage. As the respiratory disorders are increasing from pollution and other factors, the demands for nasal drug delivery equipment has also increased. On observing the current market trends, the global nasal drug delivery market is expected to touch a 07 % annual growth mark during the survey period.

Also Read : https://www.medgadget.com/2020/06/covid-19-impact-on-nasal-drug-delivery-market-2020-global-industry-share-size-opportunity-manufacturers-growth-factors-statistics-data-trends-competitive-landscape-and-regional-forecast-to-202.html

The introduction of technologically advanced equipment and rising demands are some of the major factors boosting the market structures. The nasal drug intake is gaining prevalence because, in some cases, the consumption of drugs from the nasal route has shown impressive results when compared to the oral intake procedures. Also, the demands for non-invasive techniques and less painful treatment procedures are boosting the needs and the market.

Nasal drug delivery does not require the visit to the doctor, but on understanding the dosage and usage, they can be used for self-medication, which makes it easy for the patients. Apart from all the positive features, the global nasal drug delivery market is fighting against factors like damages to nasal track and cells, and low bioavailability. The doctors and patients are still using these types of equipment due to their effectiveness, easy applications, and faster results.

Nasal Drug Delivery Market segments

The global nasal drug delivery market is segmented into five parts mentioned below:

System-based: These equipment employ unit dose, multi-dose, and metered dose systems.

Techniques: Inhalers, sprays, nebulizers, and other technologies are used.

Dosage types: drug doses are available in the powder, gel, spray, drop, and other forms.

Drugs types: Antibiotic, painkiller, antihistamines, calcium supplements, and other types of drugs are there.

Uses: Nasal drug delivery equipment is used for asthma, chronic obstructive pulmonary disease (COPD), nasal congestion, and other respiratory disorders.

Nasal Drug Delivery Market Regional Summary

The major regions observed for the global nasal drug delivery market are America, Europe, Asia Pacific, and The Middle East & Africa

The American region is the current market leader with North America as the major shareholder due to the presence of major manufacturers, demands the latest technologies in healthcare, increasing cases of respiratory patients, and other factors. The European region is the next biggest market because of demands for better healthcare alternatives, improving healthcare facilities, and rising investments in research & developments.

The Asia Pacific region is the next market in this tally but will show the highest growth rates during the survey period. Increasing respiratory disorders, rising per capita income shares, demands for better medicines, vast population cover and other factors are driving the market in this region

The rest of the regions are also showing considerable growth rates due to increasing awareness and improving healthcare structures.

Nasal Drug Delivery Market Key Players

GlaxoSmithKline Plc. (UK), AstraZeneca (UK), Pfizer, Inc. (US), Becton Dickson & Company (US), Dr. Reddy’s Laboratories Ltd. (India), Sanofi-Aventis (UK), Merck & Co. (US), Cadila Pharmaceuticals (India), AEGIS THERAPEUTICS LLC (US), Novartis AG (UK) , Johnson & Johnson Services, Inc (US) and 3M COMPANY (US) are some of the key players in the global nasal drug delivery market.

Nasal Drug Delivery Industry News

The global nasal drug delivery market is shifting gears and gaining speed. Still, the factors like low bioavailability and side effects to the nasal track are somehow slowing down the market’s growth. The North American region is leading the herd currently, whereas the Asia Pacific region will emerge as the fastest-growing market.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

…TOC Continued..

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Telehealth Market Research Report 2019 Analysis And Forecast To 2024

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “ Telehealth Market Research Report – Forecast To 2024” Gives Industry Size, Top Players And Worldwide Demand

Telehealth Market Scope

Market Research Future (MRFR) has revealed in its new extensive study that the telehealth market 2020 can expect to record a striking growth rate of 22.74% from 2016 to 2024 (assessment period). By 2024, the market is anticipated to touch USD 16,173.8 million, adds MRFR. We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.

Also Read : https://www.medgadget.com/2020/08/coronavirus-covid-19-impact-on-telehealth-market-size-2020-share-analysis-industry-growth-cagr-value-competitive-landscape-top-telehealth-companies-regional-outlook-projection.html

Telehealth Market Growth Boosters and Main Barriers

Prior to the COVID-19 outbreak, telehealth had already gained sufficient momentum and since the pandemic, the technology has garnered more interest from the growing tech-savvy population worldwide. The lockdown measures owing to SARS-CoV-2 have compelled healthcare professionals and patients to opt for remote healthcare. At present, telehealth is not just a supplementary option but has become an essential aspect of the healthcare sector. The market growth is further induced by the rising need for healthcare access from any location, escalating cases of chronic illnesses, scarcity of physicians and the surge in technological innovations in telecommunications. Telehealth is progressively gaining traction in the field of cardiology, radiology, online consultation and behavioral health, which can be a promising factor in market growth.

Governments have been a big help in reducing the challenges posed by the novel coronavirus, by increasingly relaxing their standards and regulations pertaining to healthcare. For instance, in March 2020, the Health and Human Services Office (US Department) waived off the fines for any HIPAA violation to boost the uptake of video conferencing apps such as Zoom, Facetime, WhatsApp and more that don’t comprise the necessary security features.

The market attractiveness is also bolstered by the increasing number of start-ups and new launches, in particular for virtual consultations. To cite a reference, in August 2020, the Pune Smart City Development Corporation Ltd (India) launched a telehealth app to facilitate faster healthcare access to patients, especially given the surge in COVID-19. The app can be used via smartphones or any other devices and the users will be offered live visual/audio consultation, simpler scheduling, fast registration, EMR or HMIS integrations, smoother clinical documentation, summaries and visit notes.

Given the debilitating impact of COVID-19 (Coronavirus) on Telehealth Market, companies are on the lookout for starting production lines. Get an inside look at the market prospects and its future decisions in light of the pandemic and other such unforeseen circumstances.

Telehealth Market Segmentation

Global Telehealth Market, by Component

Services
- Remote Monitoring
- Real-Time Interactions
- Store-and-Forward Consultations

Hardware
- Monitoring Devices
  - Stationary
  - Wearable
- Medical Peripherals
  - Blood Pressure Monitors
  - ECG Monitors
  - Pulse Oximeters
  - Blood Glucose Meters
  - Peak Flow Meters
  - Otoscopes
  - Others
- Others

Software
- Integrated Software
- Standalone Software

Global Telehealth Market, by Mode of Delivery

Web/Cloud-Based
On-Premise

Global Telehealth Market, by Application

Radiology
Cardiology
Primary Care
Neurophysiology
Others

Component, mode of delivery, application, and end user are the key segments as per which the telehealth industry has been considered in the MRFR study.

The telehealth market, with respect to component, can be narrowed down into software, hardware and services.

The various modes of delivery include on-premise as well as web/cloud-based. The web/cloud-based delivery mode leads the worldwide market while the on-premise category can observe the fastest growth in the following period.

The primary applications of telehealth are cardiology, radiology, neurophysiology, primary care, and more. In the lead is the radiology section, on account of the rising deployment of telehealth across the radiology field, while the cardiology segment can project the fastest expansion as a result of the accelerated increase in cardiovascular diseases worldwide.

The significant end-users in the telehealth market include home care, diagnostic clinics, hospitals and clinics and others. The biggest share in the global market belongs to hospitals and clinics while the fastest gaining segment can be that of diagnostic clinics.

Telehealth Market Regional Insight

The region-wise distribution of the global Telehealth Market covers the Middle East & Africa/MEA, EU/Europe, Asia Pacific/APAC, and the Americas,

Over the next couple of years, the Americas can be the world leader in the telehealth market, thanks to the high adoption rate of the technology in the US/United States. Telehealth has been at the forefront in the battle against COVID-19 in the region, with more and more people actively taking up remote monitoring and teleconsultation services. The prevalence of social distancing between patients and healthcare professionals has boosted the uptake of telehealth as well. The surge in queries with regard to SARS-CoV-2 and various other medical conditions without the need to visit the hospital has driven the preference for online consultations.

The telehealth market in Europe is the second most profitable, in terms of growth. The accelerated need for more streamlined and consistent healthcare monitoring is cited to be a chief booster in the market growth. As of 2018, Italy had been the highest gainer in the Western Europe telehealth market, with a share of 12.4%, reveals MRFR.

APAC is all set to be the fastest gaining market in the foreseeable future, as a result of the expanding geriatric populace and the alarming rise in chronic diseases. The lack of technical personnel as well as the insufficient access to efficient healthcare services has been a major issue in various parts of the region. Therefore, governments have sharpened their focus on offering medical facilities at remote areas via virtual care platforms. For this, pilot projects are being developed, which can mean considerable profits for the telehealth market in the ensuing years.

Telehealth Market Leading Vendors

Some of the leading vendors outlined in the extensive report include Allscripts Healthcare Solutions (US), Siemens (Germany), Cisco Systems Inc. (US), Care Innovations LLC (US), Medtronic PLC (Ireland), Honeywell International Inc. (US), InTouch Technologies Inc. (US), Livecare Health (Canada), AMD Global Telemedicine Inc. (US), Boston Scientific Corporation (US), American Well (US), Cerner Corporation (US), Maple (Canada), Philips Healthcare (Netherlands), Dialogue (Canada), GlobalMed (US), Right Health (Canada), to list a few.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/telehealth-market-900

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

COVID-19 Diagnostics Market Expected To Boost During 2019 To 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “COVID-19 Diagnostics Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

COVID-19 Diagnostics Market Analysis

The global COVID-19 diagnostics market is expected to exhibit a solid 6.28% CAGR over the forecast period from 2020 to 2027, according to the latest research report from Market Research Future (MRFR). The global COVID-19 diagnostics market is expected to reach a valuation of close to USD 96.3 billion by 2027. The research report profiles the global COVID-19 diagnostics market in great detail and provides readers with a comprehensive overview of the market. The market’s historical growth trajectory, present conditions, and future growth prospects are studied in the report. The report provides a comprehensive overview of the market’s historical growth trajectory by detailing the historical stats regarding the market. Future projections are based on the detailed historical stats offered in the report.

Also Read : https://www.medgadget.com/2020/07/covid-19-diagnostics-market-driven-by-growing-prevalence-of-coronavirus.html

Based on this platform, future projections for the COVID-19 diagnostics market’s growth trajectory over the forecast period are provided in the report. The report also profiles the leading players in the global COVID-19 diagnostics market and gives readers a comprehensive analysis of the leading players in the global COVID-19 diagnostics market. The report also profiles the major drivers and restraints affecting the global COVID-19 diagnostics market. The factors making the market tick and those holding the market back are studied in detail in the report. The impact of the COVID-19 pandemic on the COVID-19 diagnostics market is also assessed in the report.

COVID-19 is a disease caused by a strain of the coronavirus. It primarily affects the lungs and results in fever and inability to breathe. The growing global pandemic of COVID-19 has been the major driver for the global COVID-19 diagnostics market over the last few months. Over the last few months, COVID-19 cases have risen at a rapid rate all over the world, including developed as well as developing countries. This has driven the demand for effective COVID-19 diagnostics in the last few months. Due to the growing threat of the coronavirus, the demand for effective diagnostic testing kits has grown at a rapid rate. This is likely to remain the major driver for the COVID-19 diagnostics market over the forecast period. The market has excellent prospects over the short term, as governments as well as private agencies have made significant purchases of COVID-19 diagnostics.

The market’s future is uncertain in the long term, as once a vaccine to coronavirus is found, the demand for COVID-19 diagnostics is likely to decrease significantly. However, the temporary boost to the market due to the coronavirus pandemic is likely to be favorable to a number of players in the market.

COVID-19 Diagnostics Market Competitive Leaderboard:

Leading players in the global COVID-19 diagnostics market include Siemens AG, Qiagen, Thermo Fisher Scientific, Genmark Diagnostics, Biomerieux SA, F. Hoffman-La Roche Ltd., Abbott, Danaher Corporation, Bio-Rad Laboratories, and Becton Dickinson and Company.

In May 2020, Thermo Fisher Scientific received a U.S. government contract to provide highly specialized viral transport media for coronavirus sample collection.

In April 2020, Becton Dickinson and Company received an Emergency Use Authorization from the U.S. FDA.

COVID-19 Diagnostics Market Segmentation:

The global COVID-19 diagnostics market is segmented on the basis of type, technology, end use, and region.

By type, the global COVID-19 diagnostics market is segmented into molecular tests and serology tests.

By technology, the global COVID-19 diagnostics market is segmented into RT PCR, isothermal amplification, CRISPR, ELISA, hybridization, and others.

By end use, the global COVID-19 diagnostics market is segmented into hospitals, public health labs, and private and commercial labs. The hospitals segment held a dominant share in the global COVID-19 diagnostics market in 2021 and is likely to remain the leading segment of the COVID-19 diagnostics market over the forecast period.

COVID-19 Diagnostics Market Regional Analysis:

Europe is likely to dominate the global COVID-19 diagnostics market over the short term, due to the growing number of COVID-19 cases in countries such as Italy, the UK, France, and Germany. These countries have featured near the top of the most number of patients suffering from COVID-19 and are likely to remain in the lead in the coming months, leading to a growing demand for COVID-19 diagnostics.

…Continued

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/covid-19-diagnostics-market-9710

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Clear Aligners Market Size And Key Trends In Terms Of Volume And Value 2019

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Clear Aligners Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

The Global Clear Aligners Market is all set to gain a CAGR of 20.80% during the forecast period (2018-2023). This speculation is getting backed by Market Research Future (MRFR) and further predicts a possibility of scaling a USD 3,982.30 million valuation by the end of 2023.

Market Overview:

Maintaining an appearance has become quite important with burgeoning chances of exposure due to digitalization. That is why markets related to various aesthetic upliftment are getting much prominence. Same is true for the clear aligners market. Death aligner is a type of orthodontic device that helps in the alignment of teeth. Clear aligners are an improvisation of this traditional model of braces. These clear aligners get made from clear plastics and fit perfectly inside the mouth. The advantage of these aligners is the clean look it provides.

Also Read : https://www.globenewswire.com/news-release/2019/04/29/1811384/0/en/Clear-Aligners-Market-to-Touch-USD-3-982-30-million-Revenue-by-2023-at-20-80-CAGR-Says-Market-Research-Future.html

Aesthetic enhancement, driven by various mediums such as social sites, can be considered a driving factor for the resurgence of braces. This, along with, technological advancements, has created a ground for clear aligners market to solidify its existence and flourish in the coming years. The dental industry is, at present, quite blessed by advents in technologies. Meanwhile, a rise in expenditure is boosting the clear aligners market. It is gaining fast traction among the young generation.

Despite such advantages, the clear aligners market can be daunted by several factors such as treatment time it takes and cheaper alternatives that are available in the market. At the same time, like any market the knowledge of the procedure should reach a wider audience to expect larger market percolation. In the case of clear aligners, this is true as well. In developing nations with high density of population with a potential to emerge as a lucrative market opportunity, exhibits low awareness. These factors are quite a blow for the clear aligners market and could prevent the same from having a free run in coming years.

Head-to-Head

Among several companies active in the clear aligners market Danaher Corporation, Dentsply Sirona, Align Technology, Inc., Clarus Company, Institut Straumann AG, and 3M have been profiled in the MRFR report owing to their robust contribution in the market. These companies are making strategic moves that often include merger, acquisition and other methods to take the market forward and brighten their market prospect.

Industry News

In February 2019, Ormco launched Spark which would join the market later this year. On the other hand, In April 2019, Bay Materials, a market leader in orthodontic clear aligner therapy, announced that their products Zendura FLX and standard Zendura materials got approval of Brazil's ANVISA regulatory system. This step would help them in expanding their market proliferation in Latin America.

Market at a Glance

A closer look at the clear aligners market reveals segmentations by product type, distribution channels, and age. This is for a comprehensive understanding of the global market and how it would behave during the forecast period. The data provided in the report contains both volume-wise and value-wise information of segments.

Based on the product type, the global clear aligners market can be segmented into hard, medium, and soft. The hard type segment is expected to reign over the market in coming years with a 21.04% CAGR during the forecast period. The market valuation could easily scale a valuation of USD 2,994.38 million by the end of 2023. By distribution channels, the clear aligners market can be segmented into direct sales, laboratories, and others. The direct sales segment had 78% of the market share in 2017 and it could climb up to USD 3,185.47 million with a CAGR of 21.28% over the assessment period. The laboratories segment is gaining fast traction as well and is promising enough to achieve 21.31% CAGR during the forecast period. By age, the clear aligners market can be segmented into adult and teenager. The adult segment holds the maximum market share and its valuation could exceed USD 2,996.59 million by the end of 2023. The teenager segment could expand with a CAGR of 21.90% during the review period.

Mapping the Global Dynamics

Region-specific analysis of the global Clear Aligners Market includes the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). The Americas is contributing the most to the global market and it is expected to gain a valuation of USD 2,161.22 million by the end of 2023. The market expansion in the region has the twin benefits of increasing healthcare expenditure and awareness regarding upliftment of the aesthetic look. The regional market is also getting backed by superior healthcare infrastructure and implementation of advanced technologies. Europe’s role is also quite significant in taking the global market ahead. Its growing expenditure in research and development is bolstering the regional market. However, it is the APAC that can score big with 24.97% CAGR during the forecast period.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/clear-aligners-market-6974

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com